Resource

Generative AI company Abridge scores $300M series E backed by a16z and Khosla Ventures

Abridge’s technology is now deployed in more than 150 health systems

Join our Newsletter

Get insights delivered to your inbox.

Download Resource

Enter your email to get access to the resource

View Full Resource

Access directly from its original publisher.

Share

more Resources

Resources

Jul 2025

The Pulse - July 2025

News

Jun 2025

CNBC Disruptor 50: ElevateBio CEO Ger Brophy on AI and CRISPR for rare disease

Insights

Oct 2024

Life Sciences Assessment and Strategic Growth Opportunities for the Pittsburgh Region